Table 1.
Correlation of micorRNA-9 expression levels with clinicopathological features of patients with HCC
| Clinicopathological features | Number of cases | miR-9 expression | P value | |
|---|---|---|---|---|
|
|
||||
| High (n, %) | Low (n, %) | |||
| Age (y) | 1.000 | |||
| < 60 | 25 | 12 | 13 | |
| ≥ 60 | 35 | 18 | 17 | |
| Gender | 0.411 | |||
| Male | 40 | 22 | 18 | |
| Female | 20 | 8 | 12 | |
| Tumor size (cm) | 0.01 | |||
| < 5 | 28 | 9 | 19 | |
| ≥ 5 | 32 | 21 | 11 | |
| Number of tumor | 0.595 | |||
| Single | 37 | 17 | 20 | |
| Multiple | 23 | 13 | 10 | |
| Venous invasion | 0.001 | |||
| - | 34 | 10 | 24 | |
| + | 26 | 20 | 6 | |
| Tumor capsule | 0.034 | |||
| With integral | 23 | 7 | 16 | |
| Without integral | 37 | 23 | 14 | |
| HBsAg | 0.171 | |||
| - | 20 | 7 | 13 | |
| + | 40 | 23 | 17 | |
| AFP (μg/L) | 0.111 | |||
| < 400 | 37 | 22 | 15 | |
| ≥ 400 | 23 | 8 | 15 | |
| Admondson stage | < 0.001 | |||
| I-II | 35 | 8 | 27 | |
| III | 25 | 22 | 3 | |